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TO THE EDITOR
A number of genome-wide association
studies have observed an association
between single-nucleotide polymor-
phisms (SNPs) located in 5p15.33 and
an increased risk for a range of cancers,
including some non-melanoma skin
cancers (Baird, 2010). Contrary to the
increased risk observed for other cancers,
the peak variant, rs401681 C allele, has
been associated with a decreased risk
for melanoma (odds ratio (OR)¼0.86,
95% confidence interval (CI) 0.81–0.91,
P¼ 5.0 108; Stacey et al., 2009).
There have been two attempts at inde-
pendent replication. Nan et al. (2011)
observed a similar direction of effect in
a small sample (OR¼ 0.73, 95% CI
0.59–0.91). However an additional
replication study observed no evidence
for association between rs401681 C
allele and melanoma (OR¼ 1.01, 95%
CI 0.87–1.19) (Pooley et al., 2010). As
replication has been inconsistent, we
present here unpublished Australian
data and rationalize the findings.
The 5p15.33 SNPs are located within
or adjacent to two genes in strong linkage
disequilibrium (LD), encoding telomer-
ase reverse transcriptase (TERT, MIM:
187270) and CLPTM1-like protein
(CRR9p; CLPTM1L, MIM: 612585).
CLPTM1L was identified as upregulated
in cisplatin-resistant cancer cells (Yama-
moto et al., 2001) and, although a role
for CLPTM1L should not be excluded,
little is known about its function. TERT
is a striking candidate, as it encodes the
catalytic subunit of telomerase. Incom-
plete replacement of telomere repeat
sequences by telomerase following their
loss during S phase is a likely cause
of cell senescence (Shawi and Autexier,
2008). Although TERT expression is
generally absent in adult tissues, it is
enhanced in most, but not all, cancerous
cells (Engelhardt et al., 1997; Kolquist
et al., 1998). Nevi (moles) result from
melanocyte proliferation, and nevus
count is positively associated with mel-
anoma risk. Longer telomeres have
been associated with increased nevus
count and size, as well as with a non-
significant increase in melanoma risk
(OR¼ 1.85, 95% CI 0.99–3.44; Han
et al., 2009). Nan et al. (2011) reported
a marginal association between the
rs401681 C allele and shorter telomere
length, an intriguing result given their
earlier observation of decreased nevus
count in those with shorter telomere
length (Han et al., 2009). Specifically,
rs401681 C may associate with reduced
melanoma incidence via shortened telo-
mere-mediated inhibition of nevus growth.
However a far larger study observed no
association between rs401681 and telo-
mere length (Pooley et al., 2010).
We recently conducted a large mela-
noma genome-wide association study in
a Caucasian population by combining
2,168 cases from the Q-MEGA (Queens-
land study of Melanoma: Environment
and Genetic Associations; Baxter et al.,
2008) and AMFS (Australian Melanoma
Family Study; Cust et al., 2009) studies
Abbreviations: AMFS, Australian Melanoma Family Study; CLPTM1L, CLPTM1-like protein; Q-MEGA,
Queensland study of Melanoma: Environment and Genetic Associations; TERT, telomerase reverse
transcriptase
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and 4,387 controls combined from three
studies (Baxter et al., 2008; Cust et al.,
2009; Painter et al., 2011). This popula-
tion gave sufficient power to detect
effect sizes in line with other cancer
genome-wide association studies
(1.2oORo1.5). Samples were geno-
typed on Illumina SNP arrays (Cases:
Omni1-Quad or HumanHap610; Con-
trols: Omni1-Quad or HumanHap610 or
HumanHap670). Cases and controls
were combined into a single data set
for quality control, outlier removal, and
imputation. Imputation via MACH2 (Li
et al., 2010) based on the 1000 Genomes
Project data, June 2010 release (Durbin
et al., 2010), allowed association testing
for 5,480,804 well-imputed SNPs
(r240.5). Locuszoom (Pruim et al.,
2010) was used to plot SNP significance
values across the region spanning TERT
and CLPTM1L, which confirms that
there is indeed an association peak
between TERT and CLPTM1, albeit below
genome-wide significance (Figure 1).
Although imputation is able to fill in the
missing data in cases in which SNPs were
not present on all arrays used, there
remain regions in which SNPs could not
be well imputed, which in our case is a
30 kb block within TERT. However, those
SNPs directly genotyped in this region
were not meaningfully associated with
melanoma (boxed squares, Figure 1),
indicating that the association signal
between TERT and CLPTM1L does not
extend into this region. The key SNP
rs401681 is not on Omni1-Quad arrays. It
was hence genotyped separately using the
Sequenom platform (Brown et al., 2008).
In the combined Australian data
set, the rs401681 allele C was clearly
inversely associated with melanoma as
previously observed but did not reach
genome-wide significance (P¼ 0.00107,
Table 1). Meta-analysis of the rs401681
C allele across all four studies supports
the association with reduced melanoma
rates (Stacey et al., 2009; Pooley et al.,
2010; Nan et al., 2011). As the I2 value
was high at 48.98, the random-effect
model was most appropriate (random
effect P¼3.00 104, OR¼ 0.873,
95% CI 0.812–0.939; fixed effect
P¼ 91010, OR¼0.871, 95% CI
0.833–0.910). A forest plot is available
in the Supplementary Figure S1 online.
rs401681 was not our highest associa-
tion signal in this region. The strongest
association for TERT–CLPTM1L was ob-
served at rs4975616 (Table 1), which
has previously been associated with
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Figure 1. Genome-wide association results for the TERT–CLPTM1L locus. Solid triangles represent
genotyped single-nucleotide polymorphisms (SNPs), and hollow triangles represent fully imputed SNPs.
The top imputed SNP rs13356727 is displayed as a purple diamond, and the degree of linkage
disequilibrium (r2) with all other plotted SNPs is indicated by their color. The other discussed SNPs, the
fully genotyped rs4975616 and rs401681, have been singled out. Although all other plotted P-values are
derived from the imputed dosage scores, there was insufficient information to impute SNPs well on the
whole data set for a 30 k region spanning the central part of TERT. Genotyped P-values for this 30 k region
have been included as boxed squares, indicating that the association signal does not extend into the
central part of TERT. CLPTM1L, CLPTM1-like protein; TERT, telomerase reverse transcriptase.
Table 1. Association results at the TERT–CLPTM1L locus
Association of genotyping
results with melanoma
Association of imputed
dosage scores with melanoma1
Results when
covaried by rs401681
SNP: tested
allele
N genotyped,
case/
control
Tested allele
freq, case/
control P-value OR (95% CI) r 2 2 P-value OR (95% CI) P-value OR (95% CI)
rs401681: C 2,035/4,345 0.5388/0.5697 0.001073 0.883 (0.819–0.951) NA NA NA NA NA
rs4975616: A3 2,168/4,361 0.5542/0.5899 0.000101 0.864 (0.803–0.930) 0.988 0.00021 0.869 (0.807–0.937) 0.126 0.848 (0.686–1.048)
rs13356727: A4 NA NA NA NA 0.907 9.96105 0.858 (0.795–0.926) 0.0455 0.803 (0.649–0.996)
Abbreviations: CI, confidence interval; CLPTM1L, CLPTM1-like protein; NA, not applicable; OR, odds ratio; SNP, single-nucleotide polymorphism; TERT,
telomerase reverse transcriptase.
1Total population following imputation was 2,168 cases and 4,387 controls; rs4975616’s imputation P-value is generated using the combination of
genotyped and imputed data, while rs13356727 is fully imputed.
2r2 is a measure of imputation quality; it is equivalent to the ratio between the variance of the imputed genotypes and the expected binomial variance
2P (1–P) at Hardy–Weinberg equilibrium, where P is the estimated allele frequency (Li et al., 2010).
3Genotyped SNP most associated with melanoma.
4Imputed SNP most associated with melanoma.
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lung cancer (Broderick et al., 2009), and
higher again at the fully imputed
rs13356727 (Table 1). rs13356727
lies less than 10 kb from rs401681, and
is also between TERT and CLPTM1L
(Figure 1). All three SNPs exhibit strong
LD (r240.8) with one another (Supple-
mentary Figure S3 online), and all fall
within the same LD block that spans the
TERT promoter and the 30 end of the
CLPTM1L gene (Supplementary Figure
S2 online). The signal at rs13356727
remained significant following covaria-
tion by rs401681 (Table 1). Similarly,
covariation by rs13356727 abolished
all signals at rs401681 (C allele P¼
0.512, OR¼1.071, 95% CI 0.873–
1.312). When each SNP was covaried
by the other two, only rs13356727
remained significant (P¼0.046, OR¼
0.804, 95% CI 0.649–0.996). This suggests
that rs13356727 represents a better proxy
for the potential causal variant in this
region, leading to a reduced risk for
melanoma. As nevus count is also asso-
ciated with melanoma, we hypothesized
that the inverse association of rs13356727
with melanoma may have resulted from
an interaction with mole count. Self-
reported mole count (‘‘None’’, ‘‘Few’’,
‘‘Some,’’ and ‘‘Many’’) was available for
1,398 controls and for 1,592 cases with
melanoma. Covarying for mole count did
not meaningfully change the association
between rs13356727 and melanoma
(subset melanoma association P¼
4.88105, OR¼0.800, 95% CI 0.718–
0.891; subset covaried by mole count
P¼3.01 104, OR¼0.816, 95% CI
0.731–0.911). The protective rs13356727
A allele was also associated with a
reduction in mole count (regression of
self-reported mole count on rs13356727
100,000 permutations, P¼ 0.00042). The
rs401681 C and rs4975616 A alleles were
also associated with reduced mole count
to a lesser extent (Pperm¼0.00407 and
Pperm¼ 0.00069, respectively).
In conclusion, we examined the role
of TERT–CLPTM1L variants in deter-
mining melanoma risk by presenting
new data on a large Australian case–-
control sample. Combining these data
with inconclusive existing data clarifies
that TERT–CLPTM1L variants do influ-
ence risk, albeit with a relatively small
effect size. In our data, there was an
association with mole count, and it is
intriguing to speculate that the inverse
association (relative to other cancers)
may be because of an interaction with
nevus propensity. However, the observed
melanoma association was unchanged
by correction with mole count, and
further work is required to dissect the
specific role variation that TERT–
CLPTM1L has in mole count and mela-
noma. When considered in the light
of studies by Nan et al. (2011) and Han
et al. (2009), it may be that the apparently
independent association we observed
between this loci and melanoma or mole
count was due to a functional variant
influencing telomere length, which in
turn altered melanoma and nevus devel-
opment in a complex manner.
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